Synlab share: price development and company profile at a glance

Synlab share: price development and company profile at a glance

According to a report by m.ariva.de, the price of Synlab shares is currently hardly changed compared to the last quote on the previous trading day. At the moment there is only a minus of 0.08 percent on the price board, which corresponds to a reduction of 1 cent. The current price of Synlab shares is 11.80 euros. So far today, the share has performed worse than the SDAX, which is up 0.95 percent.

The company SYNLAB AG provides clinical laboratory and medical diagnostic services mainly in Europe. It offers coronavirus testing and medical and veterinary diagnostic services. SYNLAB AG was founded in 1998 and is headquartered in Munich, Germany.

The Synlab share price shows little change, which could indicate a stable market for clinical laboratory and medical diagnostic services. The relatively stable price development despite the positive trend of the SDAX indicates possible uncertainty among investors or consolidation in the industry. The general demand for medical diagnostic services is likely to influence the further development of Synlab shares.

Synlab shares could continue to benefit from increasing demand for coronavirus tests and other diagnostic services, which could have a positive impact on their price performance. However, there is also the possibility that uncertainties in the market or competitive pressure could lead to a stagnation or decline in the price.

Overall, despite the current stability, Synlab shares have certain risks that should be carefully monitored.